The Evidence Based Rheumatology Podcast

← The Evidence Based Rheumatology Podcast29. Juni · 16 Min.

E137: Obexelimab in IgG4-RD (INDIGO)

E137: Obexelimab in IgG4-RD (INDIGO)29. Juni16 Min.
In Spotify hörenFunktioniert auch im Browser
5 weitere Apps

Another day, another B cell drug. This one adds an interesting option for IgG4-RD, offering a "maybe less efficacious maybe less toxic" pathway. I could see folks being excited for this, especially in a disease where non-scary-manifestations are relatively common.

Also, check out boardsbank.com!

Paper: https://www.nejm.org/doi/full/10.1056/NEJMoa2601337